Duality Advisers, LP Adaptive Biotechnologies Corp Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$6.4 - $14.73 $68,377 - $157,375
-10,684 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$10.12 - $28.9 $108,122 - $308,767
10,684 New
10,684 $148,000
Q2 2021

Aug 09, 2021
SELL
$32.22 - $44.59 $1.87 Million - $2.59 Million
-58,064 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$37.26 - $67.74 $2.16 Million - $3.93 Million
58,064 New
58,064 $2.34 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email